HKHelena Kallio

Helena Kallio

*This is an algorithmically generated author record based on publicly available information.

Helena Kallio has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Spinal hyperbaric ropivacaine-fentanyl for day-surgery

    by Helena Kallio, Eljas-Veli T. Snäll, Sami J. Suvanto, Carl A. Tuomas, Mauri K. Iivonen, Juha-Pekka Pokki, Per H. Rosenberg

    Adequate intraoperative analgesia combined with faster mobilization might be achieved by replacing hyperbaric ropivacaine partly with fentanyl. Sixty spinal anesthesia patients were randomized into 2 groups of either fentanyl 20 μg mixed with hyperbaric ropivacaine 10 mg (group FR10) or hyperbaric ropivacaine 15 mg (group R15). Forty-five patients underwent inguinal hernia repair and 15 patients had lower extremity surgery. Sensory block was tested by pinprick, and motor block was tested by use of a modified Bromage scale at 5-minute intervals for 30 minutes, 15-minute intervals for 60 minutes, and at 30-minute intervals until full recovery. The groups did not differ significantly regarding success (27 of 30 [group FR10] and 29 of 30 [group R15]), median onset time (10 [5 to 25] v 10 [5 to 20] minutes) or median duration of T10 sensory block (55 [20 to 115] v 80 [5 to 170] minutes), respectively. Recovery from spinal block was significantly quicker in group FR10 than in group R15, recorded in ability to walk (2.5 hours v 3 hours [P = .017]), full motor recovery (1 hour v 1.5 hour [P < .001]), and sensory recovery to S1 (2.5 hours v 3.3 hours [P = .026]). Pruritus occurred in 18 (60%) of group FR10 v 0 of group R15 patients (P < .001). This symptom was mild in all except 1 patient, who received ondansetron 8 mg IV. In the OR, the groups did not differ hemodynamically: 9 (30%) of the group FR10 and 10 (33%) of the group R15 patients, respectively, required medication for hypotension and/or bradycardia. Full motor block (Bromage 3) developed less frequently (P < .001) in group FR10 patients than in group R15 patients (1 [3%] v 14 [47%]), and the group FR10 patients recovered faster in a median time of 60 v 90 minutes (P < .001). In both groups, sensory and motor blocks were more extensive on the operative side compared with the nonoperative side (P < .001). Faster mobilization but equal onset and duration of analgesia were achieved with intrathecal hyperbaric ropivacaine 10 mg plus fentanyl 20 μg as compared with hyperbaric ropivacaine 15 mg.


  • Open Access

    Comparison of hyperbaric and plain ropivacaine 15 mg in spinal anaesthesia for lower limb surgery

    by H. Kallio, E.-V. T. Snäll, C. A. Tuomas, P. H. Rosenberg

    Background. Previously, plain ropivacaine 15 mg given intrathecally has been shown to be feasible for ambulatory surgery of lower-extremities. Hypothetically, hyperbaric solution could improve and shorten the block. Methods. This prospective, randomized, double-blind study included 56 patients undergoing surgery of lower extremities. They received intrathecally either 1.5 ml of ropivacaine 10 mg ml−1 and 0.5 ml of glucose 300 mg ml−1 (HYP) or 2 ml of ropivacaine 7.5 mg ml−1 (PL). Results. All patients in Group HYP achieved T10 dermatome analgesia but only 64% (18/28) of Group PL. T10 analgesia was reached in 5 min (median, range 5–20 min) in the HYP group vs 10 min (5–45 min) in the PL group (P=0.022), and full motor block in 10 min (5–45 min) vs 20 min (5–60 min) (P=0.003), respectively. Group HYP had a longer duration of analgesia at T10; 83 min (5–145 min) vs 33 min (0–140 min) (P=0.004). Duration of sensory block from injection of the anesthetic to complete recovery was shorter in Group HYP than in Group PL, 210 min (120–270 min) vs 270 min (210–360 min) (Pvs 210 min (120–330 min) (PP=0.009). Conclusion. In comparison with the plain solution, 15 mg of intrathecal hyperbaric ropivacaine produced a faster onset, greater success rate of analgesia at the level of T10 dermatome, and faster recovery of the block.


  • A Comparison of Intrathecal Plain Solutions Containing Ropivacaine 20 or 15 mg Versus Bupivacaine 10 mg

    by Helena Kallio, Eljas-Veli T. Snäll, Markku P. Kero, Per H. Rosenberg

    Ropivacaine, which blocks sensory nerve fibers more readily than motor fibers, is considered to be less potent than bupivacaine. Our hypothesis was that, when used in spinal anesthesia for day surgery, ropivacaine 15 and 20 mg would provide faster motor recovery than bupivacaine 10 mg. This prospective, randomized, double-blinded study included 90 ambulatory lower-extremity surgery patients who received 2 mL of ropivacaine 1%, ropivacaine 0.75%, or bupivacaine 0.5%. Motor block was tested with the Bromage scale, and sensory block was tested with pinprick. Ropivacaine 15 mg provided faster recovery of motor block (150 min) than did bupivacaine 10 mg (210 min; P = 0.005), but the median duration of sensory block at T10 (140 min) did not differ significantly from that with bupivacaine 10 mg (140 min). The median duration of sensory block at T10 was significantly longer with ropivacaine 20 mg (170 min) than with bupivacaine 10 mg (140 min; P = 0.005), but the median recovery from motor block (210 min) did not differ significantly. We conclude that the duration of sensory block of ropivacaine was two thirds and the duration of motor block was half when compared with bupivacaine, with calculations based on the duration-per-milligram of the local anesthetic.